Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.

Aubert P, Suárez-Fariñas M, Mitsui H, Johnson-Huang LM, Harden JL, Pierson KC, Dolan JG, Novitskaya I, Coats I, Estes J, Cowen EW, Plass N, Lee CC, Sun HW, Lowes MA, Goldbach-Mansky R.

PLoS One. 2012;7(11):e49408. doi: 10.1371/journal.pone.0049408. Epub 2012 Nov 30.

2.

Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.

Goldbach-Mansky R.

Curr Rheumatol Rep. 2011 Apr;13(2):123-31. doi: 10.1007/s11926-011-0165-y. Review.

3.
4.

[Cutaneous neutrophils infiltrates. Case 8. CINCA/NOMID syndrome].

Fraitag S.

Ann Pathol. 2011 Jun;31(3):203-7. doi: 10.1016/j.annpat.2011.05.005. Epub 2011 Jun 12. French. No abstract available.

PMID:
21737003
5.

Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).

Haverkamp MH, van de Vosse E, Goldbach-Mansky R, Holland SM.

Clin Exp Immunol. 2014 Sep;177(3):720-31. doi: 10.1111/cei.12361.

6.

"Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.

Hedrich CM, Bruck N, Paul D, Hahn G, Gahr M, Rösen-Wolff A.

Rheumatol Int. 2012 Sep;32(9):2629-36. doi: 10.1007/s00296-011-2019-3. Epub 2011 Jul 22.

PMID:
21833523
7.

Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, Upchurch GR Jr, Ailawadi G.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):294-304. doi: 10.1161/ATVBAHA.112.300432. Epub 2013 Jan 3.

8.

Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.

Koné-Paut I, Galeotti C.

Expert Rev Clin Immunol. 2015;11(10):1083-92. doi: 10.1586/1744666X.2015.1077702. Epub 2015 Aug 27. Review.

PMID:
26312542
9.

Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes.

Bachove I, Chang C.

Open Access Rheumatol. 2014 Mar 3;6:15-25. eCollection 2014. Review.

10.

Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment.

Boschan C, Witt O, Lohse P, Foeldvari I, Zappel H, Schweigerer L.

Am J Med Genet A. 2006 Apr 15;140(8):883-6.

PMID:
16532456
11.

Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.

Johnston WF, Salmon M, Pope NH, Meher A, Su G, Stone ML, Lu G, Owens GK, Upchurch GR Jr, Ailawadi G.

Circulation. 2014 Sep 9;130(11 Suppl 1):S51-9. doi: 10.1161/CIRCULATIONAHA.113.006800.

12.

Treating inflammation by blocking interleukin-1 in humans.

Dinarello CA, van der Meer JW.

Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23. Review.

13.

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, Pinto G, Pagnier A, Bodemer C, Bodaghi B, Tardieu M, Prieur AM, Quartier P.

Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.

14.

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.

Sibley CH, Plass N, Snow J, Wiggs EA, Brewer CC, King KA, Zalewski C, Kim HJ, Bishop R, Hill S, Paul SM, Kicker P, Phillips Z, Dolan JG, Widemann B, Jayaprakash N, Pucino F, Stone DL, Chapelle D, Snyder C, Butman JA, Wesley R, Goldbach-Mansky R.

Arthritis Rheum. 2012 Jul;64(7):2375-86. doi: 10.1002/art.34409.

15.

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE Jr, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O'Shea JJ, Kastner DL, Goldbach-Mansky R.

Arthritis Rheum. 2002 Dec;46(12):3340-8.

16.

Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.

Brydges SD, Broderick L, McGeough MD, Pena CA, Mueller JL, Hoffman HM.

J Clin Invest. 2013 Nov;123(11):4695-705.

17.

Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.

Kanariou M, Tantou S, Varela I, Raptaki M, Petropoulou C, Nikas I, Valari M.

Pediatrics. 2014 Nov;134(5):e1468-73. doi: 10.1542/peds.2013-3185.

18.

Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation.

Rodriguez-Smith J, Lin YC, Tsai WL, Kim H, Montealegre-Sanchez G, Chapelle D, Huang Y, Sibley CH, Gadina M, Wesley R, Bielekova B, Goldbach-Mansky R.

Arthritis Rheumatol. 2017 Jun;69(6):1325-1336. doi: 10.1002/art.40055. Epub 2017 May 10.

PMID:
28118536
19.

Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.

Sadeghi H, Lockmann A, Hund AC, Samavedam UK, Pipi E, Vafia K, Hauenschild E, Kalies K, Pas HH, Jonkman MF, Iwata H, Recke A, Schön MP, Zillikens D, Schmidt E, Ludwig RJ.

J Immunol. 2015 Apr 15;194(8):3656-63. doi: 10.4049/jimmunol.1402688. Epub 2015 Mar 20.

20.

Interleukin-1β in innate inflammation, autophagy and immunity.

Joosten LA, Netea MG, Dinarello CA.

Semin Immunol. 2013 Dec 15;25(6):416-24. doi: 10.1016/j.smim.2013.10.018. Epub 2013 Nov 22.

PMID:
24275601

Supplemental Content

Support Center